Virafin for moderate Covid 19

April 26, 2021

The Drugs Controller General of India (DGCI) on Friday approved the emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b ‘Virafin’ for treating moderate COVID-19 infection for adults. Zydus Cadila announced that it has received emergency use approval from DCGI to use Virafin for the treatment of moderate COVID-19 infections. As per the report, a single-dose subcutaneous regimen of the drug will make the treatment of COVID-19 more convenient. The company had said that if administered early on during COVID-19, Virafin may help patients recover faster and avoid much of the complications. It will be available on the prescription of a medical specialist.

Share this story

Virafin for moderate Covid 19

RELATED NEWS

STF deploys 17 teams against organised crime

Teacher recruitment must protect education quality, Prime Minister tells Parliament

Sri Lanka in continuing talks with India over bottom trawling, Nalinda tells Parliament

School hours to remain unchanged under 2027 education reforms

STF deploys 17 teams against organised crime

Teacher recruitment must protect education quality, Prime Minister tells Parliament

Sri Lanka in continuing talks with India over bottom trawling, Nalinda tells Parliament

Whom the Gods would destroy, they first make mad!

School hours to remain unchanged under 2027 education reforms

CA Sri Lanka proposes AI-powered tax compliance system for 2027 Budget

Litro to release 350,000 gas cylinders over next three days

Low-pressure area moves west but rain to continue across Sri Lanka

Lanka, Romania discuss protection of 26,000 Lankan workers